GAITHERSBURG, Md., Nov. 4, 2024 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a worldwide firm advancing protein-based vaccines with its Matrix-M™ adjuvant, immediately introduced it is going to report its third quarter 2024 monetary outcomes and operational highlights at 8:30 a.m. Japanese Time (ET) on Tuesday, November 12, 2024. Particulars of the occasion and replay are as follows:
- Members can be part of the convention name with out operator help by registering and coming into their telephone quantity with the above URL to obtain an prompt automated name again.
- Members also can dial direct to be entered into the decision by an operator and can be prompted to request to hitch the Novavax, Inc. name.
- To make sure a well timed connection, it’s endorsed that members be part of no less than 10 minutes previous to the scheduled webcast.
|
Replay particulars: |
|
|
Date: |
Accessible beginning at 11:30 a.m. ET, November 12, 2024, till 11:59 p.m. U.S. ET, November 19, 2024 |
|
Dial-in quantity: |
(888) 660-6345 (Home) or |
|
(+1) (646) 517-4150 (Worldwide) |
|
|
Passcode: |
62491 # |
|
Webcast: |
ir.novavax.com/occasions, till December 12, 2024 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved well being by discovering, creating and commercializing revolutionary vaccines to assist defend in opposition to severe infectious ailments. Novavax, a worldwide firm based mostly in Gaithersburg, Md., U.S., gives a differentiated vaccine platform that mixes a recombinant protein strategy, revolutionary nanoparticle know-how and Novavax’s patented Matrix-M adjuvant to reinforce the immune response. The Firm’s portfolio consists of its COVID-19 vaccine and its pipeline consists of COVID-19-Influenza Mixture and stand-alone influenza vaccine candidates. As well as, Novavax’s adjuvant is included within the College of Oxford and Serum Institute of India’s R21/Matrix-M malaria vaccine. Please go to novavax.com and LinkedIn for extra data.
Contacts:
Traders
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-third-quarter-2024-financial-results-and-operational-highlights-on-november-12-2024-302295599.html
SOURCE Novavax, Inc.
